IPM 028
Status:Completed
Phase:I
Principal Investigator(s):
Objective:This trial investigated the potential drug-drug interaction between dapivirine vaginal Ring-004 and vaginally administered miconazole nitrate, and evaluated the safety of co-administration of the dapivirine vaginal ring and miconazole nitrate in healthy, HIV-negative women.
Prevention Option(s):Microbicides
Study Design:Open label, Randomized
Arms and Assigned Interventions
DescriptionActive Comparator: Dapivirine Ring + Miconazole
Mode of DeliveryRing
ARMsExperimental
DescriptionExperimental: Dapivirine Ring
Mode of DeliveryRing
ARMsExperimental
Official Code:
NCT01731574
Trial Sponsors:
IPM
Start Date
End Date
February 18, 2016
October 12, 2013
Enrollment:36
Age range:
18 Years ↔
40 Years
Population:Cisgender Women